Should pregnant women with diabetes be counseled differently if nephropathy was detected? a population database study

References

• Feig DS, Hwee J, Shah BR, et al. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care. 2014;37(6):1590–1596.
   PubMed Web of Science ®Google Scholar
• Velez MP, Slater M, Griffiths R, et al. Diabetes during pregnancy and perinatal outcomes among first nations women in Ontario, 2002/03-2014/15: a population-based cohort study. CMAJ Open. 2020;8(1):E214–E225.
   PubMedGoogle Scholar
• Xia Y, Xie Z, Huang G, et al. Incidence and trend of type 1 diabetes and the underlying environmental determinants. Diabetes Metab Res Rev. 2019;35(1):e3075
   PubMed Web of Science ®Google Scholar
• Adeniji AO, Atanda OO. Randomized comparison of effectiveness of unimodal opioid analgesia with multimodal analgesia in post-cesarean section pain management. J Pain Res. 2013;6:419–424.
   PubMed Web of Science ®Google Scholar
• Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007;30(7):1920–1925.
   PubMed Web of Science ®Google Scholar
• Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304(22):1331–1334.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49(12):2208–2211.
   PubMed Web of Science ®Google Scholar
• Holmes VA, Young IS, Patterson CC, et al.; for the Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34(8):1683–1688.
   PubMed Web of Science ®Google Scholar
• Lim A. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361–381.
   PubMedGoogle Scholar
• Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2018;42(Suppl 1):S1–S325.
   PubMedGoogle Scholar
• Oliverio AL, Bragg-Gresham JL, Admon LK, et al. Obstetric deliveries in US women with ESKD: 2002-2015. Am J Kidney Dis. 2020;75(5):762–771.
   PubMed Web of Science ®Google Scholar
• Carr DB, Koontz GL, Gardella C, et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens. 2006;19(5):513–519.
   PubMed Web of Science ®Google Scholar
• Young EC, Pires ML, Marques LP, et al. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes. Diabetes Metab Syndr. 2011;5(3):137–142.
   PubMedGoogle Scholar
• How HY, Sibai B, Lindheimer M, et al. Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus? Am J Obstet Gynecol. 2004;190(3):775–778.
   PubMed Web of Science ®Google Scholar
• Klemetti MM, Laivuori H, Tikkanen M, et al. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011. Diabetologia. 2015;58(4):678–686.
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–551.
   PubMedGoogle Scholar
• Buscemi J, Saiyed N, Silva A, et al. Diabetes mortality across the 30 biggest U.S. cities: assessing overall trends and racial inequities. Diabetes Res Clin Pract. 2021;173:108652.
   PubMed Web of Science ®Google Scholar
• Towne SD, Yeary KHK, Narcisse MR, et al. Inequities in access to medical care among adults diagnosed with diabetes: comparisons between the US population and a sample of US-Residing marshallese islanders. J Racial Ethn Health Disparities. 2020;8(2):375–383.
   PubMed Web of Science ®Google Scholar
• Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab. 2000;26(Suppl 4):54–63.
   PubMedGoogle Scholar
• Su S, Wang W, Sun T, et al. Smoking as a risk factor for diabetic nephropathy: a Meta-analysis. Int Urol Nephrol. 2017;49(10):1801–1807.
   PubMed Web of Science ®Google Scholar
• Buettner M, Toennes SW, Buettner S, et al. Nephropathy in illicit drug abusers: a postmortem analysis. Am J Kidney Dis. 2014;63(6):945–953.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Viteri OA. Diabetic ketoacidosis in pregnancy. Obstet Gynecol. 2014;123(1):167–178.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Group DER, DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16.
   PubMed Web of Science ®Google Scholar
• Maislos M, Harman-Bohem I, Weitzman S. Diabetic ketoacidosis. A rare complication of gestational diabetes. Diabetes Care. 1992;15(8):968–970.
   PubMed Web of Science ®Google Scholar
• Madaan M, Aggarwal K, Sharma R, et al. Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases. J Reprod Med. 2012;57(9-10):452–455.
   PubMed Web of Science ®Google Scholar
• Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care. 2001;24(10):1739–1744.
   PubMed Web of Science ®Google Scholar
• Reece EA, Leguizamon G, Homko C. Stringent controls in diabetic nephropathy associated with optimization of pregnancy outcomes. J Matern Fetal Med. 1998;7(4):213–216.
   PubMedGoogle Scholar
• Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM. 1999;92(8):451–454.
   PubMedGoogle Scholar
• ACOG Committee Opinion No 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44–e52.
   PubMed Web of Science ®Google Scholar
• Kimmerle R, Zass RP, Cupisti S, et al. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia. 1995;38(2):227–235.
   PubMed Web of Science ®Google Scholar
• Ritz E. Anemia and diabetic nephropathy. Curr Diab Rep. 2006;6(6):469–472.
   PubMedGoogle Scholar
• Kerssen A, Evers IM, de Valk HW, et al. Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med. 2003;13(5):309–313.
   PubMedGoogle Scholar
• Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–2451.
   PubMed Web of Science ®Google Scholar
• Kennedy D, Koren G. Identifying women who might benefit from higher doses of folic acid in pregnancy. Can Fam Physician. 2012;58(4):394–397.
   PubMed Web of Science ®Google Scholar
• Chitayat D, Matsui D, Amitai Y, et al. Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update. J Clin Pharmacol. 2016;56(2):170–175.
   PubMed Web of Science ®Google Scholar
• Wilson RD, Wilson RD, Audibert F, Special Contributors, et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic Acid-Sensitive congenital Anomalies. J Obstet Gynaecol Can. 2015;37(6):534–552.
   PubMedGoogle Scholar
• Tsakiridis I, Mamopoulos A, Athanasiadis A, et al. Management of pregestational diabetes mellitus: a comparison of guidelines. J Matern Fetal Neonatal Med. 2020;28:1–10.
   Google Scholar